Cargando…
The official French guidelines to protect patients with cancer against SARS-CoV-2 infection
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118635/ https://www.ncbi.nlm.nih.gov/pubmed/32220659 http://dx.doi.org/10.1016/S1470-2045(20)30204-7 |
| _version_ | 1783514601856434176 |
|---|---|
| author | You, Benoit Ravaud, Alain Canivet, Anne Ganem, Gérard Giraud, Philippe Guimbaud, Rosine Kaluzinski, Laure Krakowski, Ivan Mayeur, Didier Grellety, Thomas Lotz, Jean-Pierre |
| author_facet | You, Benoit Ravaud, Alain Canivet, Anne Ganem, Gérard Giraud, Philippe Guimbaud, Rosine Kaluzinski, Laure Krakowski, Ivan Mayeur, Didier Grellety, Thomas Lotz, Jean-Pierre |
| author_sort | You, Benoit |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7118635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71186352020-04-03 The official French guidelines to protect patients with cancer against SARS-CoV-2 infection You, Benoit Ravaud, Alain Canivet, Anne Ganem, Gérard Giraud, Philippe Guimbaud, Rosine Kaluzinski, Laure Krakowski, Ivan Mayeur, Didier Grellety, Thomas Lotz, Jean-Pierre Lancet Oncol Comment Elsevier Ltd. 2020-05 2020-03-25 /pmc/articles/PMC7118635/ /pubmed/32220659 http://dx.doi.org/10.1016/S1470-2045(20)30204-7 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment You, Benoit Ravaud, Alain Canivet, Anne Ganem, Gérard Giraud, Philippe Guimbaud, Rosine Kaluzinski, Laure Krakowski, Ivan Mayeur, Didier Grellety, Thomas Lotz, Jean-Pierre The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title | The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title_full | The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title_fullStr | The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title_full_unstemmed | The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title_short | The official French guidelines to protect patients with cancer against SARS-CoV-2 infection |
| title_sort | official french guidelines to protect patients with cancer against sars-cov-2 infection |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118635/ https://www.ncbi.nlm.nih.gov/pubmed/32220659 http://dx.doi.org/10.1016/S1470-2045(20)30204-7 |
| work_keys_str_mv | AT youbenoit theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT ravaudalain theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT canivetanne theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT ganemgerard theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT giraudphilippe theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT guimbaudrosine theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT kaluzinskilaure theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT krakowskiivan theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT mayeurdidier theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT grelletythomas theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT lotzjeanpierre theofficialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT youbenoit officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT ravaudalain officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT canivetanne officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT ganemgerard officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT giraudphilippe officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT guimbaudrosine officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT kaluzinskilaure officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT krakowskiivan officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT mayeurdidier officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT grelletythomas officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection AT lotzjeanpierre officialfrenchguidelinestoprotectpatientswithcanceragainstsarscov2infection |